Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia ... in patients aged 12 and older and is the first drug in the anti-TFPI class to be approved in ...
Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA) drug, Xeljanz, which is the first approved RA treatment in a new class of medicines known as Janus kinase inhibitors ...
Severe hemophilia A is a genetic disorder that prevents blood from clotting properly, posing a constant risk of dangerous ...
The healthcare industry thrives due to novel drug pipeline discoveries, AI integration to streamline processes and ...
Roivant will discontinue the development of its drug for a rare lung ... bleeding disorder called hemophilia, the company said on Friday. US FDA approves Pfizer's drug for rare bleeding disorder ...
NEW YORK, October 11, 2024--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI ... of age and older with hemophilia A (congenital ...
A drug developed by Sanofi raised platelet counts and reduced bleeding episodes in patients with a rare autoimmune disorder ...
Over the course of the pandemic, the risk of developing long COVID after a COVID-19 infection decreased, largely due to vaccination. Payer costs for COVID-19 ranged from a mean of $505 for ...
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
The U.S. Food and Drug Administration has approved a drug developed at Stanford Medicine that offers hope to people diagnosed ...
Merus’ week keeps getting better. Days after securing a long-awaited commercialization partner for its zenocutuzumab, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback